Drugs
Jan Leschly, the chief executive of SmithKline Beecham, has a pay, perks, and shares package worth over £90 million, making it the largest ever awarded by a public company in the UK. The package, valued at £20 million more than 12 months ago, dwarfs previous executive rewards and is likely
Pharmaceutical industry
Monsanto Company and Zeneca Agrochemicals have entered into a significant long-term license agreement, under which Zeneca will test, develop, and register "Touchdown" herbicide products for use on or over the top of Roundup Ready soybeans, corn, and cotton in the United States. This partnership marks a significant development
Pharmaceutical industry
DuPont Co., a global chemical company, has made its first significant move in the life sciences sector by acquiring 80 percent of Pioneer Hi-Bred International Inc., the world's largest seed corn company, for a staggering $7.7 billion. This deal marks a significant consolidation in the agribusiness industry,
Drugs
Amidst a bustling news cycle, Australian financial markets anticipate a rally this week, bolstered by Wall Street's Dow Jones index surging close to the 10,000-point milestone. Meanwhile, a series of local and global news stories continue to dominate headlines, from East Timor's independence struggle to
Drugs
A class action lawsuit was filed in the United States District Court Eastern District of Pennsylvania against Cell Pathways, Inc. (CPI) on behalf of all purchasers of CPI common stock during a specific period between November 3, 1998, and February 2, 1999. The lawsuit alleges that CPI and certain officers
Drugs
A class action lawsuit has been filed on behalf of purchasers of Cell Pathways, Inc. securities between November 1, 1998, and February 2, 1999, for alleged violations of federal securities laws. The lawsuit, brought by law firm Weiss & Yourman, charges Cell Pathways, Inc., and certain of its officers and
Drugs
A class action lawsuit was filed in the United States District Court Eastern District of Pennsylvania against Cell Pathways, Inc. (CPI) on behalf of all purchasers of CPI common stock during a specific period between November 3, 1998, and February 2, 1999. The lawsuit alleges that CPI and certain officers
Drugs
Weiss & Yourman, a law firm with extensive experience in prosecuting class actions on behalf of investors and shareholders, has filed a class-action lawsuit against Cell Pathways Inc. and certain of its officers and directors. The lawsuit alleges violations of federal securities laws, specifically Sections 10(b) and 20(a)
Drugs
CIMA Labs, a leader in oral drug delivery systems, has reached a significant milestone in its collaboration with Zeneca, a global biopharmaceutical company. The partnership has led to the submission of a regulatory filing in Europe for Zeneca's migraine treatment, Zomig, in the form of an OraSolv fast-dissolve
Drugs
IMS Health, the world's leading provider of information solutions to the pharmaceutical and healthcare industries, has announced that Zeneca Pharmaceuticals has signed a multi-year contract for IMS Health's full line of sales management software and services in the United States. The contract was awarded following an
Drugs
Shares in Glaxo-SmithKline and Glaxo Wellcome have remained buoyant despite the collapse of merger talks last March, with the combined value of the companies rising to $20bn thanks to speculation of an imminent deal. However, the deal ultimately fell through, leaving shareholders, including Carol Galley from Mercury Asset Management, holding
Drugs
Xenometrix, a biotechnology company specializing in gene expression profiling technology, has granted its eighth license agreement to SmithKline Beecham, giving the pharmaceutical company access to claims covered in issued U.S. and European patents. This non-exclusive license covers the collection of gene expression profiles using all methods, including high-density microarrays.
